PRKACA anticorps (Lys82, N-Term)
Aperçu rapide pour PRKACA anticorps (Lys82, N-Term) (ABIN2340987)
Antigène
Voir toutes PRKACA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Lys82, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- PRKACA, NT (K82) (cAMP-dependent Protein Kinase Catalytic Subunit alpha, PKA C-alpha, PKACA)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Synthetic peptide selected from the N-terminal(K282) region of human PRKACA (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.84 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
Autre désignation
- PRKACA
-
NCBI Accession
- NP_002721
-
UniProt
- P17612
-
Pathways
- Signalisation NF-kappaB, Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
Antigène
-